Sivextro
Active Ingredient(s): Tedizolid PhosphateFDA Approved: * June 20, 2014
Pharm Company: * CUBIST PHARMS
Category: Skin Care
Tedizolid (formerly torezolid, trade name Sivextro),[3] is an oxazolidinone-class antibiotic. Tedizolid phosphate is a phosphate ester prodrug of the active compound tedizolid. It was developed by Cubist Pharmaceuticals, following acquisition of Trius Therapeutics (originator: Dong-A Pharmaceuticals), and is marketed for the treatment of acute bacterial skin and skin structure infections (also known as complicated skin and skin-structure infections (cSSSIs)).[4]... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.